Dr. Jen Caudle flags gaps in what social media says about retatrutide, the Lilly drug still in trials, and asks viewers to comment for more.
Recap by typeshit. Post by @drjencaudle on Instagram.
The Times looks at current options for the facial volume loss that can come with rapid GLP-1 weight loss. Full details are on the site.
A Facebook clip has a doctor explaining concerns about muscle loss and hair thinning in people taking GLP-1 medications.
Health NZ is warning that many peptides people inject are unapproved and unregulated, even as demand for the kits keeps growing.
The writer argues the headline merges separate stories, from FDA approval to an 80% visceral fat figure, and says the details don't hold together.
Part of his GLP-1 series, Krittanawong explains how PAD limits blood flow to the legs and causes pain when walking, and asks whether these drugs could help.
Weill Cornell's Dhruv Khullar says vials he had lab tested showed lead, endotoxins, and one held half the advertised dose. Experts warn against 'vibes-based' trust.
Loading…